乾癬の初期リサンキズマブ治療における単一細胞制御ネットワーク解析による併用薬候補の特定
Yupeng Ma1, Shumin Zhang2, Xinhong Chen3
1University of Shanghai for Science and Technology School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai 200093, China.
Current pharmaceutical design
|January 23, 2026
まとめ
この研究では、主要な転写因子を特定し、乾癬治療のためのリサンキズマブの代替薬または併用薬として、アリトレチノインやシンバスタチンなどの5つの低分子薬を予測しました。
科学分野:
- 免疫学
- 皮膚科学
- 計算生物学
背景:
- リサンキズマブは乾癬に有効ですが、コストや潜在的な副作用などの限界があります。
- 乾癬の代替療法または併用療法の特定は臨床的に重要です。
研究 の 目的:
- 乾癬の初期リサンキズマブ治療における免疫細胞の転写制御を特徴づけること。
- 乾癬の潜在的な治療標的および低分子薬を特定すること。
主な方法:
- 樹状細胞およびCD4+ T細胞からの単一細胞RNAシーケンシングデータの解析。
- 差次的発現、細胞間コミュニケーション、および転写因子ネットワーク解析が実施されました。
- 低分子薬予測および分子ドッキングが利用されました。
主要な成果:
- リサンキズマブの初期治療中にCD4+ T細胞で15の主要な転写因子が有意に変化しました。
- 皮膚バリア機能に関連する下流の差次的発現遺伝子が同定されました。
- 5つの候補薬(アリトレチノイン、シンバスタチン、MS-275、コルヒチン、(+)-サンギナリン)が予測されました。
結論:
- 乾癬のリサンキズマブ治療中の転写変化を特徴づけました。
- 潜在的な治療標的および低分子薬が特定されました。
- 本研究の結果は、乾癬管理のための将来的な併用戦略を示唆しています。
関連する概念動画
Cis-regulatory Sequences
11.6K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.6K
Cis-regulatory Sequences
4.1K
4.1K
Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Protein Networks
2.8K
2.8K
Drug Control Governance: Regulatory Bodies and Their Impact
508
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
508
Network Covalent Solids
16.1K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.1K


